Difference between revisions of "Part:BBa K3599037"
Line 9: | Line 9: | ||
===Sequence and Features=== | ===Sequence and Features=== | ||
<partinfo>BBa_K3599037 SequenceAndFeatures</partinfo> | <partinfo>BBa_K3599037 SequenceAndFeatures</partinfo> | ||
+ | |||
+ | |||
+ | ===Reference=== | ||
+ | Kang, S. Y., Choi, O., Lee, J. K., Ahn, J. O., Ahn, J. S., Hwang, B. Y., & Hong, Y. S. (2015). Artificial de novo biosynthesis of hydroxystyrene derivatives in a tyrosine overproducing Escherichia coli strain. <i>Microbial cell factories</i>, 14(1), 1-11. [https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-015-0268-7 10.1186/s12934-015-0268-7] |
Latest revision as of 14:41, 27 October 2020
seTAL
an enzyme which was designed into the artificial biosynthesis pathway of 4VA synthesis. The original function of seTAL was converting tyrosine into 4-coumaric acid. The codon usage was optimized for expression in E. coli.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Reference
Kang, S. Y., Choi, O., Lee, J. K., Ahn, J. O., Ahn, J. S., Hwang, B. Y., & Hong, Y. S. (2015). Artificial de novo biosynthesis of hydroxystyrene derivatives in a tyrosine overproducing Escherichia coli strain. Microbial cell factories, 14(1), 1-11. 10.1186/s12934-015-0268-7